Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Hormone replacement therapy and the risk of reproductive cancers
S. H. Swan
Research output
:
Contribution to journal
›
Article
›
peer-review
5
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Hormone replacement therapy and the risk of reproductive cancers'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hormone Replacement Therapy
100%
Reproductive Cancer
100%
Endometrial Cancer
33%
Progestin
33%
Breast Cancer
16%
Estrogen
16%
Older Women
16%
Breast Cancer Risk
16%
Family History
16%
Large Cohort Study
16%
Ovarian Cancer
16%
Ovarian Cancer Risk
16%
Menopause
16%
Oral Contraceptive Use
16%
Current Users
16%
Unopposed Estrogen
16%
Dose Duration
16%
Endogenous Hormones
16%
Exposure Characteristics
16%
Subject Characteristics
16%
Weak Data
16%
Medicine and Dentistry
Malignant Neoplasm
100%
Hormone Substitution
100%
Cancer Risk
33%
Breast Cancer
33%
Ovarian Cancer
33%
Uterine Cancer
33%
Gestagen
33%
Cohort Analysis
16%
Family History
16%
Oral Contraceptive Use
16%
Endogenous Hormone
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Replacement Therapy
100%
Breast Cancer
33%
Endometrium Cancer
33%
Ovary Cancer
33%
Progestin
33%
Cohort Study
16%
Oral Contraceptive
16%